Neuroimaging in Dementia: A Brief Review

Area of Science:

• Neurology
• Radiology
• Biomarker Discovery

Background:

• Dementia is a syndrome of cognitive impairment in older adults, often due to neurodegenerative diseases.
• Clinical diagnosis is primary, but biomarkers in cerebrospinal fluid (CSF) or via neuroimaging can aid early detection.
• Early diagnosis is crucial for managing dementia and its impact on the aging population.

Purpose of the Study:

• To review and assess the role of various neuroimaging modalities in the early diagnosis of common dementia etiologies.
• To evaluate the diagnostic utility of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) scans.
• To discuss the potential of neuroimaging biomarkers in dementia diagnosis.

Main Methods:

• Literature search using PubMed to identify relevant peer-reviewed articles.
• Review and synthesis of studies on the application of different neuroimaging techniques in dementia diagnosis.
• Focus on common causes of dementia and their neuroimaging characteristics.

Main Results:

• Neuroimaging techniques, including CT, MRI, PET, and SPECT, are valuable tools for the early identification of dementia.
• These methods assist in differentiating between various dementia subtypes.
• Biomarkers identified through neuroimaging show promise for early detection, even before clinical symptoms are evident.

Conclusions:

• Modern neuroimaging significantly aids in the early diagnosis and subtyping of dementia.
• Further research is needed to establish the cost-effectiveness and clinical accessibility of these advanced diagnostic tools.
• Continued development of neuroimaging biomarkers is essential for monitoring dementia progression and improving patient outcomes.